JSPR
- Jasper Therapeutics, Inc.
()
Overview
Company Summary
Jasper Therapeutics, Inc. is a biotechnology company focused on advancing the field of hematopoietic stem cell (HSC) therapy. The company aims to develop innovative and curative therapies for a range of hematological malignancies and disorders, as well as for immune and genetic diseases.
Jasper Therapeutics specializes in the use of induced pluripotent stem cells (iPSCs) as a renewable source of HSCs. iPSCs are generated by reprogramming adult cells, such as skin cells, back into a pluripotent state. These pluripotent stem cells can then be differentiated into various cell types, including functional HSCs.
The company's proprietary platform technology enables the creation of a renewable supply of HSCs, overcoming the limitations associated with traditional sources, such as bone marrow or peripheral blood. By utilizing this approach, Jasper Therapeutics seeks to provide a potentially curative treatment option for patients who currently lack suitable donor matches or have other barriers to transplantation.
Jasper Therapeutics is committed to advancing the understanding of HSC biology, optimizing their stem cell platform, and conducting rigorous clinical trials to validate their therapies. Through these efforts, the company aims to transform the standard of care for patients with hematological conditions and make a significant impact on the field of stem cell therapy.